Prevalence, Clinical Course, and Management of Depression During Pregnancy

  • Sanjog Kalra
  • Adrienne Einarson
Part of the Current Clinical Practice book series (CCP)


Depression has been identified by the World Health Organization as a major cause of morbidity in the 21st century. As women between 25 and 44 yr represent the population at highest risk for depression, a substantial number are likely to become pregnant while suffering from this illness. In this chapter, we summarize the prevalence and clinical course of depression during pregnancy. We also document evidence-based information regarding the safety and efficacy of both pharmacological and nonpharmacological treatments of prenatal depression. In addition, we discuss other issues surrounding the treatment of depression, such as abrupt discontinuation syndrome, poor neonatal adaptability, and an increase in the rate of spontaneous abortions, associated with the use of certain antidepressant drugs. Of equal importance, we also review the emerging literature on the potential adverse effects of untreated depression during pregnancy.

Depression is an important issue that must be addressed when women become pregnant. A variety of pharmacological and nonpharmacological treatment options are available, the vast majority of which appear to be relatively safe. Women suffering from depression during pregnancy must be treated individually, and the benefits and/or risks of treatment or nontreatment should be weighed carefully using evidence-based information. This approach will ensure the best possible outcomes for the mothers and their babies.


Depression pregnancy risks prevalence course treatment safety 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Buist, A. (2000) Managing depression in pregnancy. Aust Fam Physician 29(7), 663–667.PubMedGoogle Scholar
  2. 2.
    Murray, C. J. and Lopez, A. D. (1996) Evidence-based health policy lessons from the Global Burden of Disease Study. Science 274, 740–743.PubMedCrossRefGoogle Scholar
  3. 3.
    Regier, D. A., Narrow, W. E., Rae, D. S., et al. (1993) The de facto US mental and addictive disorders health system. Arch Gen Psychiatry 50, 85–94.PubMedGoogle Scholar
  4. 4.
    Kessler, R. C., McGonagie, K. A., Zhao, S., et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 51, 8–19.PubMedGoogle Scholar
  5. 5.
    Weissman, M. M., Bland, R., Joyce, P. R., et al. (1993) Sex differences in rates of depression: cross-national perspectives. J. Affect. Disord. 29, 77–84.PubMedCrossRefGoogle Scholar
  6. 6.
    Burke, K. C., Burke, J. D., Rae, D. S., et al. (1991) Comparing age at onset of major depression and other psychiatric disorders by birth cohorts in five US community populations. Arch Gen Psychiatry 48, 789–795.PubMedGoogle Scholar
  7. 7.
    Kendell, R. E., Wainwright, S., Hailey, A., et al. (1976) The influence of childbirth on psychiatric morbidity. Psychol Med. 6, 297–302.PubMedGoogle Scholar
  8. 8.
    Kumar, R., and Robson, M. (1984) A prospective study of emotional disorders in childbearing women. Br. J. Psychiatry 144, 35–47.PubMedCrossRefGoogle Scholar
  9. 9.
    Bennett, H. A., Einarson, A., Taddio, A., et al. (2004) Depression during pregnancy: overview of clinical factors. Clin. Drug Invest. 24, 157–179.CrossRefGoogle Scholar
  10. 10.
    Affonso, D. D., Lovett, S. Paul, N., et al. (1990) A standardized interview that differentiates pregnancy and postpartum symptoms from perinatal clinical depression. Birth 17, 121–130.PubMedCrossRefGoogle Scholar
  11. 11.
    McKee, M. D., Cunningham, D., Jankowski, K. R., et al. (2001) Health-related functional status in pregnancy: relationship to depression and social support in a multi-ethnic population. Obstet. Gynecol. 97, 988–993.PubMedCrossRefGoogle Scholar
  12. 12.
    Bennett, H. A., Einarson, A., Taddio, A., et al. (2004) Prevalence of depression during pregnancy: systematic review. Obstet. Gynecol. 103, 698–709.PubMedGoogle Scholar
  13. 13.
    American Psychiatric Association. (1994) Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.Google Scholar
  14. 14.
    Beck, A. T. (1961) An inventory for measuring depression. Arch. Gen. Psychiatry 4, 53–61.Google Scholar
  15. 14a.
    Beck, A. T., Rush, H. A., Shaw, B. F., and Emery, G. (1979) Cognitive Therapy of Depression. New York: Guilford Press.Google Scholar
  16. 15.
    Holcomb, W. L., Stone, L. S., Lustman, P. J., et al. (1996) Screening for depression in pregnancy: characteristics of the Beck Depression Inventory. Obstet. Gynecol. 88, 1021–1025.PubMedCrossRefGoogle Scholar
  17. 16.
    Salamero, M., Marcos, T., Gutierrez, F., et al. (1994) Factorial study of the BDI in pregnant women. Psychol. Med. 24, 1031–1035.PubMedGoogle Scholar
  18. 17.
    Cox, J. L., Holden, J. M., and Sagovsky, R. (1987) Detection of postnatal depression: development of the Edinburgh Postnatal Depression Scale. Br. J. Psychiatry 150, 782–786.PubMedCrossRefGoogle Scholar
  19. 18.
    Murray, D. and Cox, J. L. (1990) Screening for depression during pregnancy with the Edinburgh depression scale (EPDS). J. Reprod. Infant Psychol. 8, 99–107.CrossRefGoogle Scholar
  20. 19.
    Spitzer, R. L., Williams, J. B., Kroenke, K., et al. (2000) Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetricgynecology study. Am. J. Obstet Gynecol. 183, 759–769.PubMedCrossRefGoogle Scholar
  21. 20.
    Spitzer, R. L., Kroenke, K., Williams J. B. W., and the Patient Health Questionnaire Primary Care Study Group. (1999) Validation and utility of a selfreport version of PRIME-MD: The PHQ Primary Care Study. JAMA 282, 737–744.CrossRefGoogle Scholar
  22. 21.
    Pfizer Inc. (1999) PRIME-MD: Patient Health Questionnaire (PHQ). Available from Accessed June 2004.
  23. 22.
    Radloff, L.S. (1977)TheCES-Dscale: a self-report depression scale for research in the general population. Appl. Psychol. Measure. 1, 385–401.CrossRefGoogle Scholar
  24. 23.
    Radloff, L. S. and Locke, B. Z. (1986) The community mental health assessment survey and the CES-D scale. In: Weissman, M. M., Myers, J. K., and Ross, C. E., eds. Community Surveys of Psychiatric Disorders. Surveys in Psychosocial Epidemiology 4, 177–189.Google Scholar
  25. 24.
    Lorant, V., Deliege, D., Eaton, W., et al. (2003) Socioeconomic inequalities in depression: a meta-analysis. Am. J. Epidemiol. 157, 98–112.PubMedCrossRefGoogle Scholar
  26. 25.
    Boyd, R. C., Pearson, J. L., and Blehar, M. C. (2002) Prevention and treatment of depression in pregnancy and the postpartum period: summary of a maternal depression roundtable: a UA perspective. Arch. Women Ment. Health 4, 79–82.CrossRefGoogle Scholar
  27. 26.
    Collins, N. L., Dunkel-Schetter, C., Lobel, M., et al. (1993) Social supporting pregnancy: psychosocial correlates of birth outcomes and postpartum depression. J. Pers. Soc. Psychol. 6, 1243–1258.Google Scholar
  28. 27.
    Burger, J., Horwitz, S. M., Forsyth, B. W., et al. (1993) Psychological sequelae of medical complications during pregnancy. Pediatrics 91, 566–571.PubMedGoogle Scholar
  29. 28.
    Hughes, P., Turnton, P., and Evans, C. (1999) Stillbirth as a risk factor for depression and anxiety in the subsequent pregnancy: cohort study. Br. Med. J. 318, 1721–1724.Google Scholar
  30. 29.
    Kitamura, T., Sugawara, M., Sugawara, K., et al. (1996) Psychosocial study of depression in early pregnancy. Br. J. Psychiatry 168, 732–738.PubMedGoogle Scholar
  31. 30.
    Johanson, R., Chapman, G., Murray, D., et al. (2000) The North Staffordshire Maternity Hospital prospective study of pregnancy-associated depression. J. Psychosom. Obstet. Gynecol. 21, 93–97.CrossRefGoogle Scholar
  32. 31.
    Mäki, P. (2003) Parental Separation at Birth and Maternal Depressed Mood in Pregnancy: Associations with Schizophrenia and Criminality in the Offspring. Oulu, Finland: Oulu University Press.Google Scholar
  33. 32.
    Steiner, M. and Tam, W. Y. K. (1999) Postpartum depression in relation to other psychiatric disorders. In: Miller, L.J. ed. Postpartum Mood Disorders. Washington, DC: American Psychiatric Press, pp. 47–63.Google Scholar
  34. 33.
    Beck, C. T. (2002) Revision of the postpartum depression predictors inventory. J Obstet Gynecol Neonatal Nurs 31, 394–402.PubMedCrossRefGoogle Scholar
  35. 34.
    Miller, L. J. (2002) Postpartum depression. JAMA 287, 762–765.PubMedCrossRefGoogle Scholar
  36. 35.
    O’Hara, M. W. and Swain, A. M. (1996) Rates and risk of postpartum depressiona meta-analysis. Int. Rev. Psychiatry 8, 37–54.CrossRefGoogle Scholar
  37. 36.
    Beck, C. T. (2001) Predictors of postpartum depression: an update. Nurs. Res. 50, 275–285.PubMedCrossRefGoogle Scholar
  38. 37.
    Hendrick, V. and Altshuler, L. (2002) Management of major depression. Am. J. Psychiatry 159, 1667–1673.PubMedCrossRefGoogle Scholar
  39. 38.
    Beck, C. T. (1998) A checklist to identify women at risk for developing postpartum depression. J. Obstet. Gynecol. Neonatal Nurs. 27, 39–46.PubMedCrossRefGoogle Scholar
  40. 39.
    Evans, J., Heron, J., Francomb, H., et al. (2001) Cohort study of depressed mood during pregnancy and after childbirth. Br. Med. J. 323, 257–260.CrossRefGoogle Scholar
  41. 40.
    Weissman, M. M., Bland, R. C., Canino, G. J., et al. (1996) Cross-national epidemiology of major depression and bipolar depression. JAMA 276, 293–299.PubMedCrossRefGoogle Scholar
  42. 41.
    Eaton, W. W., Anthony, J. C., Gallo, J., et al. (1997) Natural history of diagnostic Interview Schedule/DSM-IV major depression: the Baltimore Epidemiologic Catchment Area follow-up. Arch. Gen. Psychiatry 54, 993–999.PubMedGoogle Scholar
  43. 42.
    Parikh, S. V. and Lam, R. W. (2001) Clinical guidelines for the treatment of depressive disorder: 1. definitions, prevalence, and health burden. Can. J. Psychiatry 46, 13–20S.Google Scholar
  44. 43.
    Thornicroft, G. and Sartorius N. (1993) The course and outcome of depression in different cultures: 10-year follow-up of the WHO collaborative study on the assessment of depressive disorders. Psychol. Med. 23, 1023–1032.PubMedGoogle Scholar
  45. 44.
    Keller, M.B. (1982) Recovery in major depressive disorder: analysis with the life table and regression models. Arch. Gen. Psychiatry 39, 905–910.PubMedGoogle Scholar
  46. 45.
    Altshuler, L. L., Hendrick, V., and Cohen, L. S. (1998) Course of mood and anxiety disorders during pregnancy and the postpartum period. J. Clin. Psychiatry 59(Suppl. 2), 29–33.PubMedGoogle Scholar
  47. 46.
    Kumar, R. and Robson, M. K. (1984) A prospective study of emotional disorders in childbearing women. Br. J. Psychiatry 144, 35–47.PubMedCrossRefGoogle Scholar
  48. 47.
    O’Hara, M. W., Zekoski, E. M., Philipps, L. H., et al. (1990) Controlled prospective study of postpartum mood disorders: comparison of childbearing and nonchildbearing women. J. Abnorm. Psychol. 1, 3–15.CrossRefGoogle Scholar
  49. 48.
    Kelly, R. H., Russo, J., and Katon, W. (2001) Somatic complaints among pregnant women cared for in obstetrics: normal pregnancy or depressive and anxiety symptom amplification revisited? Gen. Hosp. Psychiatry 23, 107–113.PubMedCrossRefGoogle Scholar
  50. 49.
    Kelly, R. H., Russo, J., Holt, V. L., et al. (2002) Psychiatric and substance use disorders as risk factors for low birth weight and preterm delivery. Obstet. Gynecol. 100, 297–304.PubMedCrossRefGoogle Scholar
  51. 50.
    Orr, S. T., James, S. A. and Blackmore Prince, C. (2002) Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland. Am. J. Epidemiol. 156, 797–802.PubMedCrossRefGoogle Scholar
  52. 51.
    Birndorf, C. A., Madden, A., Portera, L., et al. (2001) Psychiatric symptoms, functional impairment, and receptivity toward mental health treatment among obstetrical patients. Int. J. Psychiatry Med. 31, 355–365.PubMedCrossRefGoogle Scholar
  53. 52.
    Bixo, M., Sundstrom-Poromaa, I., Bjorn, I., et al. (2001) Patients with psychiatric disorders in gynecologic practice. Am. J. Obstet. Gynecol. 185, 396–402.PubMedCrossRefGoogle Scholar
  54. 53.
    Simon, G., VonKorff, M., and Barlow, W. (1995) Health care costs of primary care patients with recognized depression. Arch. Gen. Psychiatry 52, 850–856.PubMedGoogle Scholar
  55. 54.
    Committee to Study the Prevention of Low Birthweight. (1998) Etiology and Risk Factors. Washington, DC: National Academic Press.Google Scholar
  56. 55.
    Children’s Dental Health Project (2003) Periodontal disease association with poor birth outcomes: state of the science and policy implications. Available from Accessed June 2004.
  57. 56.
    Pajulo, M., Savonlahti, E., Sourander, A., et al. (2001) Antenatal depression, substance dependency and social support. J. Affect. Disord. 65, 9–17.PubMedCrossRefGoogle Scholar
  58. 57.
    Kelly, R. H., Zatzick, D. F., and Anders, T. F. (2001) The detection and treatment of psychiatric disorders and substance use among pregnant women cared for in obstetrics. Am. J. Psychiatry 158, 213–219.PubMedCrossRefGoogle Scholar
  59. 57a.
    Zuckerman, B., Amaro, H., Bauchner, H., et al. (1989) Depressive symptoms during pregnancy: relationship to poor health behaviours. Am. J. Obstet. Gynecol. 160, 1107–1111.PubMedGoogle Scholar
  60. 58.
    Paarlberg, K. M., Vingerhoets, J. J., Passchier, J., et al. (1995) Psychosocial factors and pregnancy outcome: a review with emphasis on methodological issues. J. Psychosom. Res. 39, 563–595.PubMedCrossRefGoogle Scholar
  61. 59.
    National High Blood Pressure Education Working Group. (1990) National High Blood Pressure Education Working Group report on high blood pressure in pregnancy. Am. J. Obstet. Gynecol. 163, 1689–1712.Google Scholar
  62. 60.
    Brooks, M.B. (2004) Pregnancy, pre-eclampsia. Available from http://www. Accessed June 2004.
  63. 61.
    Kurki, T., Hilesmaa, V., Raitasalo, R., et al. (2000) Depression and anxiety in early pregnancy and risk for pre-eclampsia. Obstet. Gynecol. 95, 487–490.PubMedCrossRefGoogle Scholar
  64. 62.
    Kelly, R. H., Danielsen, B., Golding, J., et al. (1999) Adequacy of prenatal care among women with psychiatric diagnoses giving birth in California in 1994 and 1995. Psychiatr. Serv. 50, 1584–1590.PubMedGoogle Scholar
  65. 63.
    Vintzileos, A., Anath, C. V., Smulian, C. V., et al. (2002) The impact of prenatal care in the United States on preterm births in the presence and absence of antenatal high-risk conditions. Am. J. Obstet. Gynecol. 187, 1254–1257.PubMedCrossRefGoogle Scholar
  66. 64.
    Vintzileos, A., Smulian, C. V., Scorza, W. E., et al. (2002) The impact of prenatal care on postnatal deaths in the presence and absence of antenatal high-risk conditions. Am. J. Obstet. Gynecol. 187, 1258–1262.PubMedCrossRefGoogle Scholar
  67. 65.
    Vintzileos, A. M., Ananth, C. V., Smulian, J. C., et al. (2002) Prenatal care and black-white fetal death disparity in the United States: heterogeneity by high-risk conditions. Obstet. Gynecol. 99, 483–489.PubMedCrossRefGoogle Scholar
  68. 66.
    Lundy, B.and Field, T. (1996) Newborns of mothers with depressive symptoms are less expressive. Infant Behav. Dev. 19, 419–424.CrossRefGoogle Scholar
  69. 67.
    Lundy, B., Jones, N. A., Field, T., et al. (1999) Prenatal depression effects on neonates. Infant Behav. Dev. 22, 119–129.CrossRefGoogle Scholar
  70. 68.
    Gitau, R., Cameron, A., Fisk, N. M., et al. (1998) Fetal exposure to maternal cortisol. Lancet 352, 707–708.PubMedCrossRefGoogle Scholar
  71. 69.
    Murray, L. (1992) The impact of postnatal depression on infant development. J. Child Psychol. 33, 543–561.CrossRefGoogle Scholar
  72. 70.
    Ferrill, M. J., Kehoc, W. A., and Jacisin, J. J. (1992) ECT during pregnancy: physiologic and pharmacologic considerations. Convuls. Ther. 8, 186–200.PubMedGoogle Scholar
  73. 71.
    Miller, L. J. (1994) Use of electroconvulsive therapy during pregnancy. Hosp. Commun. Psychiatry 45, 444–450.Google Scholar
  74. 72.
    Olfson, M., Marcus, S. C., Druss, B., et al. (2002) National trends in the outpatient treatment of depression. JAMA 287, 203–209.PubMedCrossRefGoogle Scholar
  75. 73.
    Wisner, K. L., Zarin, D. A., Holmboe, E. S., et al. (2000) Risk-benefit decision making for treatment of depression during pregnancy. Am. J. Psychiatry 157, 1933–1940.PubMedCrossRefGoogle Scholar
  76. 74.
    Spinelli, M.G. (1997) Interpersonal psychotherapy for depressed antepartum women: a pilot study. Am. J. Psychiatry 154, 1028–1030.PubMedGoogle Scholar
  77. 75.
    Spinelli, M. G. and Endicott, J. (2003) Controlled trial of interpersonal psychotherapy versus parenting education program for depressed women. Am. J. Psychiatry 160, 555–562.PubMedCrossRefGoogle Scholar
  78. 76.
    Cohen, L. S., Nonacs, R., Viguera, A. C., et al. (2004) Diagnosis and treatment of depression during pregnancy. CNS Spectr. 9, 206–216.Google Scholar
  79. 77.
    Portnoi, G., Chng, L. A., Karimi-Tabesh, L., et al. (2003) Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. Am. J. Obstet. Gynecol. 189, 1374–1377.PubMedCrossRefGoogle Scholar
  80. 78.
    Einarson, A., Phillips, E., Mawji, F., et al. (1998) A prospective controlled multicentre study of clarithromycin in pregnancy. Am. J. Perinatol. 15, 523–525.PubMedGoogle Scholar
  81. 79.
    Fabro, S. E. (1987) Clinical Obstetrics. New York: John Wiley.Google Scholar
  82. 80.
    Baldessarini, R. J. (2001) Drugs and the treatment of psychiatric disorders: depression and anxiety disorders. In: Hardman, J. G., Limbird, L. E., Goodman Gilman, A., eds. The Pharmacological Basis of Therapeutics, 10th ed. New York: McGrawHill, pp. 447–483.Google Scholar
  83. 81.
    McBride, W. G. (1972) Limb deformities associated with iminodibenzyl hydrochloride [letter]. Med. J. Aust. 1, 492.PubMedGoogle Scholar
  84. 82.
    McElhatton, P. R., Garbis, H. M., Eléphant, E., et al. (1996) The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European network of teratology information services (ENTIS). Reprod. Toxicol. 10, 286–294.CrossRefGoogle Scholar
  85. 83.
    Pastuszak, A., Schick-Bschetto, B., Zuber, C., et al. (1993) Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 269(17), 2246–2248.PubMedCrossRefGoogle Scholar
  86. 84.
    Morrow, A. W. (1972) Imipramine and congenital abnormalities [letter]. NZ Med. J. 75, 228–229.Google Scholar
  87. 85.
    Heinonen, O. P., Slone, D. and Shapiro, S. (1977) Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Services Group.Google Scholar
  88. 86.
    Misri, S. and Sivertz, K. (1991) Tricyclic drugs in pregnancy and lactation: a preliminary report. Int. J. Psychiatry Med. 21, 157–171PubMedGoogle Scholar
  89. 87.
    Altshuler, L. L., Cohen, L., Szuba, M. P., et al. (1996) Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am. J. Psychiatry 153, 592–606.PubMedGoogle Scholar
  90. 88.
    Briggs, G. G., Freeman, R. K., and Yaffe, S. J. (2002) Drugs in Pregnancy and Lactation, 6th ed. Philidelphia: Lippincott Williams and Wilkins.Google Scholar
  91. 89.
    Shearer, W. T., Schreiner, R. L., and Marshall, R. E. (1972) Urinary retention in a neonate secondary to maternal ingestion of nortriptyline. J. Pediatr. 81, 570–572.PubMedCrossRefGoogle Scholar
  92. 90.
    Petersen, T., Dording, C., Neault, N.B., et al. (2002) A survey of prescribing practices in the treatment of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 177–187.PubMedCrossRefGoogle Scholar
  93. 91.
    Preskorn, S. H. and Fast, G. A. (1991) Therapeutic drug monitoring for antidepressants: efficacy, safety and cost effectiveness. J. Clin. Psychiatry 52(Suppl.), 23–33.PubMedGoogle Scholar
  94. 92.
    Preskorn, S. H. and Burke, M. (1992) Somatic therapy for major depressive disorder: selection of an antidepressant. J. Clin. Psychiatry 53(Suppl. 1), 5–18.PubMedGoogle Scholar
  95. 93.
    Pohland, R. C., Byrd, T. K., Hamilton, M., et al. (1989) Placental transfer and fetal distribution of fluoxetine in the rat. Toxicol. Appl. Pharmacol. 98, 198–205.PubMedCrossRefGoogle Scholar
  96. 94.
    Heikkine, T., Ekblad, U., and Laine, K. (2002) Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta. Br J Obstet Gynaecol 109, 1003–1008.Google Scholar
  97. 95.
    Hendrick, V., Stowe, Z. N., Altshuler, L. L., et al. (2003) Placental passage of antidepressant medications. Am. J. Psychiatry 160, 993–996.PubMedCrossRefGoogle Scholar
  98. 96.
    Goldstein, D. J. (1995) Effects of third trimester fluoxetine exposure on the newborn. J. Clin. Psychopharmacol. 15, 417–420.PubMedCrossRefGoogle Scholar
  99. 97.
    Chambers, C. D., Johnson, K. A., Dick, L. M., et al. (1996) Birth outcomes in pregnancy women taking fluoxetine. N. Engl. J. Med. 335, 1010–1015.PubMedCrossRefGoogle Scholar
  100. 98a.
    Hendrick, V., Smith, L. M., Suri, R., et al. (2003) Birth outcomes following prenatal exposure to antidepressant medications. Am. J. Obstet. Gynecol. 188, 812–815.PubMedCrossRefGoogle Scholar
  101. 99.
    Ericson, A., Källén, B., and Wiholm, B. E. (1999) Delivery outcome after the use of antidepressants in early pregnancy. Eur. J. Clin. Pharmacol. 55, 503–508.PubMedCrossRefGoogle Scholar
  102. 100.
    Cohen, L. S., Heller, V. L., Bailey, J. W., et al. (2000) Birth outcomes following prenatal exposure to fluoxetine. Biol. Psychiatry 48, 996–1000.PubMedCrossRefGoogle Scholar
  103. 101.
    Simon, G. E., Cunnignham, M. L., and Davis, R. L. (2002) Outcomes of prenatal antidepressant exposure. Am. J. Psychiatry 159, 2055–2061.PubMedCrossRefGoogle Scholar
  104. 102.
    Koren, G., Pastuzak, A., and Ito, S. (1998) Drugs in pregnancy. N. Engl. J. Med. 338, 1128–1137.PubMedCrossRefGoogle Scholar
  105. 103.
    Robert, E. (1996) Treating depression in pregnancy [editorial]. N. Engl. J. Med. 335, 1056–1058.PubMedCrossRefGoogle Scholar
  106. 104.
    Nulman, I., Rovet, J., Stewart, D.E., et al. (1997) Neurodevelopment of children exposed in utero to antidepressant drugs. N. Engl. J. Med. 336, 258–262.PubMedCrossRefGoogle Scholar
  107. 105.
    Kulin, N. A., Pastuszak, A., Sage, S. R., et al. (1998) Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors. A prospective controlled multicenter study. JAMA 279, 609–610.Google Scholar
  108. 106.
    Costei, A. M., Kozer, E., Ho, T., et al. (2002) Perinatal outcome following third trimester exposure to paroxetine. Arch. Pediatr. Adolesc. Med. 156, 1129–1132.PubMedGoogle Scholar
  109. 106c.
    Williams, M. and Wooltorton, E. (2005) Paroxetine (Paxil) and congenital malformations. CMAJ, 173(11), 1320–1321.Google Scholar
  110. 107.
    Heikkinen, T., Ekblad, U., Kero, P., et al. (2002) Citalopram in pregnancy and lactation. Clin. Pharmacol. Ther. 72, 184–191.PubMedCrossRefGoogle Scholar
  111. 107a.
    Sivojelezova, A., Shuhaiber, S., Sarkissian, L., et al. (2003) Citalopram use in pregnancy: evaluation of fetal risk [abstract]. Ottawa, ON: Canadian Society of Clinical Pharmacology.Google Scholar
  112. 107b.
    Hostetter, A., Ritchie, J. C., and Stowe, Z. N. (2000) Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women. Biol. Psychiatry 48, 1032–1034.PubMedCrossRefGoogle Scholar
  113. 108.
    Einarson, F., Fatoye, B., Sarkar, M., et al. (2001) Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am. J. Psychiatry 158, 1728–1730.PubMedCrossRefGoogle Scholar
  114. 109.
    Ward, H. E. (1997) The newer antidepressants. IM Intern. Med. 18, 65–76.Google Scholar
  115. 110.
    Ascher, J. A., Cole, J. O., Colin, J. N., et al. (1995) Bupropion: a review of its mechanism of antidepressant activity. J. Clin. Psychiatry 56, 395–401.PubMedGoogle Scholar
  116. 111.
    Einarson, A. and Koren, G. (2004) New antidepressants in pregnancy. Can. Fam. Physician 50, 227–229.PubMedGoogle Scholar
  117. 112.
    Chan, B. F., Koren, G., Fayez, I., et al. (2005) Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am. J Obstet. Gynecol. 192, 932–936.CrossRefGoogle Scholar
  118. 113.
    Lambers, D. S. and Clark, K. E. (1996) The maternal and fetal physiologic effects of nicotine. Semin. Perinatol. 20(2), 115–126.CrossRefGoogle Scholar
  119. 114.
    Benowitz, N. L. (1991) Nicotine replacement therapy during pregnancy. JAMA 266(22), 3174–3177.CrossRefGoogle Scholar
  120. 115.
    O’Campo, P., Davis, M., and Gielen, A. (1995) Smoking cessation interventions for pregnant women: review and future directions. Semin. Perinatol. 19(4), 229–225.Google Scholar
  121. 116.
    Stillman, R. J., Rosenberg, M. J., and Sachs, B. P. (1986) Smoking and reproduction. Fertil. Steril. 46(4), 545–566.Google Scholar
  122. 117.
    Werler, M., Pober, B., and Holmes, L. (1985) Smoking and pregnancy. Teratology 32, 473–481.PubMedCrossRefGoogle Scholar
  123. 118.
    Abel, E. L. (1980) Smoking during pregnancy: areview of effects on growth and development of offspring. Hum. Biol. 52(4), 593–625.Google Scholar
  124. 119.
    Einarson, A., Bonari, L., Voyer-Lavigne, S., et al. (2003) A multicentre prospective controlled study to determine the safety of Trazodone and Nefazodone use during pregnancy. Can. J. Psychiatry 48, 106–110.PubMedGoogle Scholar
  125. 120.
    Kesim, M., Yaris, F., Kadioglu, M., et al. (2002) Mirtazepine use in two pregnant women: Is it safe? Teratology 66, 204.PubMedCrossRefGoogle Scholar
  126. 121.
    Goldman, R. D. and Koren, G. (2003) Taking St. John’s wort during pregnancy. Can. Fam. Physician 49, 29–30.PubMedGoogle Scholar
  127. 122.
    Muller, W. E., Singer, A., and Wonnemann, M. (1998) Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract. Pharmacopsychiatry 31(Suppl. 1), 16–21.PubMedGoogle Scholar
  128. 123.
    Nathan, P. (1999) The experimental and clinical pharmacology of St John’s wort (Hypericum perforatum). Mol. Psychiatry 4, 333–338.PubMedCrossRefGoogle Scholar
  129. 124.
    Linde, K. and Mulrow, C. D. (2000) St John’s wort for depression. Cochrane Database Syst. Rev. CD000448.Google Scholar
  130. 125.
    Woelk, H., Bukard, G., and Grunwald, J. (1994) Benefits and risks of the Hypericum extract LI 160: drug monitoring study with 3250 patients. J. Geriatr. Psychiatry Neurol. 7(Suppl. 1), S34–38.PubMedCrossRefGoogle Scholar
  131. 126.
    Schrader, E., Meier, B., and Brattstrom, A. (1998) Hypericum treatment of mildmoderate depression in a placebo-controlled study. Hum. Psychopharmacol. 13, 163–169.CrossRefGoogle Scholar
  132. 127.
    Einarson, A., Lawrimore, T., Brand, P., et al. (2000) Attitudes and practices of physicians and naturopaths toward herbal products, including use during pregnancy and lactation. Can. J. Clin. Pharmacol. 7, 45–49.PubMedGoogle Scholar
  133. 128.
    O’Hara, M. A., Keifer, D., Farrell, K., et al. (1998) A review of 12 commonly used medicinal herbs. Arch. Fam. Med. 7, 523–535.PubMedCrossRefGoogle Scholar
  134. 129.
    Grush, L. R., Nierenberg, A., Keefe, B., et al. (1998) St John’s wort during pregnancy. JAMA 280, 1566.PubMedCrossRefGoogle Scholar
  135. 130.
    Einarson, A. (2003) Abrupt discontinuation of psychotropic drugs during pregnancy. Mental Fitness. 2:26, 35–39.Google Scholar
  136. 132.
    Poulson, E.and Robson, J. M. (1964) Effect of phenelzine and some related compounds on pregnancy. J. Endocrinol. 30, 205–215.PubMedGoogle Scholar
  137. 133.
    Castiel-Levinson, R., Merlob, P., Linder, N., and Sirota, L., and Klinger, G. (2006) Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch. Pediatr. Adoles. Med. 160, 170–173.Google Scholar
  138. 134.
    Nordeng, H., Lindemann, R., Perminov, K.V, et al. (2001) Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr. 90, 228–291.CrossRefGoogle Scholar
  139. 135.
    Better news on populations. (1993) Lancet 339, 1600.Google Scholar
  140. 136.
    Einarson, A., Selby, P., and Koren, G. (2001) Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counseling. J. Psychiatry Neurosci. 26, 44–48.PubMedGoogle Scholar
  141. 137.
    Rosabaum, Z. J. (1997) Clinical management of antidepressant discontinuation. J. Clin. Psych. 58(Suppl. 7), 37–40.Google Scholar
  142. 138.
    Chambers, C. D., Hernandez-Diaz, S., van Marter, L. J., Werler, M. M., Louik, C., Jones, K. L., and Mitchell, A. A. (2006) Selective serotonin reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. NEJM 354, 579–587.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2006

Authors and Affiliations

  • Sanjog Kalra
    • 1
  • Adrienne Einarson
    • 2
  1. 1.Department of PharmacologyUniversity of Toronto and The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick ChildrenToronto
  2. 2.The Motherisk Program, Division of Clinical Pharmacology and ToxicologyThe Hospital for Sick ChildrenToronto

Personalised recommendations